Published by
@ShahidNShah
@ShahidNShah
6th Annual RAS-Targeted Drug Development Summit is sheduled on 24-26 September 2024 in Boston MA.Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology.With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance. However, treating patients with RAS mutant cancers remains no easy feat, as knowledge gaps persist in improving the depth and durability of response, tackling emerging resistance mechanisms and informing combination strategies to improve the standard-of care for patients in need.
[Read on ras-drugdevelopment.com](https://ras-drugdevelopment.com/register/)
Continue reading at ras-drugdevelopment.com
September 24 to September 26, 2024
Melia Berlin, 103 Friedrichstraße, Berlin, 10117, Germany
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Sep 6, 2024 at 12:08pm